Saladaga, Rynjake .

HRN: 22-11-69  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
CEFUROXIME 750MG (VIAL)
10/26/2022
11/02/2022
IV
530 Mg
Q8
UTI
Waiting Final Action 
10/29/2022
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
10/29/2022
11/02/2022
ORAL
1ml
Bid
Atp
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: